Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Choosing the right credit card for cash back can boost your savings. Explore options that deliver the best return on your spending.
25,914 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
The Fed's May inflation forecast could reshuffle the deck for Social Security's 2027 COLA. This guide breaks down wha...
Uniswap activated its fee switch today, enabling on-chain UNI buybacks funded by protocol fees. The move links revenu...
A new senior tax break could trim your tax bill, but not everyone will benefit in 2026. This guide explains who quali...
A sudden health update can ripple into finances. This guide turns that news into practical steps you can take today t...
Gold has emerged as a standout performer in 2026, with certain bullion-backed ETFs delivering resilience and steady g...
A single ETF dramatically refreshed the idea of index investing. This guide explains why the QQQ ETF captured investo...
Homes.com is elevating its challenge to Zillow in the online listing arena, raising the stakes for affordability. The...
Two popular small-cap growth ETFs take different routes to opportunity. This guide breaks down how IJT and ISCG work,...
Two popular U.S. tech ETFs—VGT and FTEC—often attract the same investor despite different price tags on cost and liqu...
If you’re weighing AI investing options, two popular ETFs—CHAT and XLK—show two very different paths. This guide brea...
Choosing between two popular ETFs means weighing tech-driven growth against broad small-cap diversification. This gui...